Berman Howard
- SEC CIK
- 0001952986
No open-market purchases or sales filed in the past year.
Current role at each company
- AVIR Atea Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- COYA Coya Therapeutics, Inc.Executive Chairmanas of Jan 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Berman Howard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
COYA Coya Therapeutics, Inc.
Executive Chairman2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | Berman HowardChief Executive Officer | PPurchaseCommon Stock, par value $0.0001 per share | +10.0K | – | – | New position10.0K after | Amended |
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | Berman HowardChief Executive Officer | PPurchaseCommon Stock, par value $0.0001 per share | +5.00K | – | – | –5.00K after | AmendedDerivative |